Your browser doesn't support javascript.
loading
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
Harrison, Simon J; Perrot, Aurore; Alegre, Adrian; Simpson, David; Wang, Ming Chung; Spencer, Andrew; Delimpasi, Sosana; Hulin, Cyrille; Sunami, Kazutaka; Facon, Thierry; Vlummens, Philip; Yong, Kwee; Campana, Frank; Inchauspé, Marlène; Macé, Sandrine; Risse, Marie-Laure; van de Velde, Helgi; Richardson, Paul.
Afiliación
  • Harrison SJ; Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Perrot A; Centre Hospitalo-universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France.
  • Alegre A; University Hospital La Princesa and University Hospital Quironsalud, Madrid, Spain.
  • Simpson D; North Shore Hospital, Auckland, New Zealand.
  • Wang MC; Chang Gung Medical Foundation, Taipei, Taiwan.
  • Spencer A; The Alfred Hospital, MONASH University/Australian Centre for Blood Diseases, Melbourne, Victoria, Australia.
  • Delimpasi S; Evangelismos Hospital, Athens, Greece.
  • Hulin C; Service d'Hématologie Hôpital Haut-Lévêque CHU, Bordeaux, France.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Facon T; Department of Haematology, Lille University Hospital, Lille, France.
  • Vlummens P; Department of Haematology, Ghent University Hospital, Ghent, Belgium.
  • Yong K; Department of Haematology, University College Hospital, London, UK.
  • Campana F; Sanofi, Cambridge, MA, USA.
  • Inchauspé M; Affiliation at time of study, currently Takeda Pharmaceuticals, Cambridge, MA, USA.
  • Macé S; IT&M Stats (for Sanofi), Neuilly-sur-Seine, Île-de-France, France.
  • Risse ML; Sanofi R&D, Vitry-sur-Seine, France.
  • van de Velde H; Sanofi R&D, Vitry-sur-Seine, France.
  • Richardson P; Sanofi, Cambridge, MA, USA.
Br J Haematol ; 194(1): 120-131, 2021 07.
Article en En | MEDLINE | ID: mdl-34036560
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Terapia Recuperativa / Ensayos Clínicos Fase III como Asunto / Mieloma Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Terapia Recuperativa / Ensayos Clínicos Fase III como Asunto / Mieloma Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Australia